Pfizer Inc. $PFE Stock Position Raised by Aviance Capital Partners LLC

Aviance Capital Partners LLC grew its holdings in Pfizer Inc. (NYSE:PFE) by 41.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 139,611 shares of the biopharmaceutical company’s stock after acquiring an additional 41,035 shares during the period. Aviance Capital Partners LLC’s holdings in Pfizer were worth $3,557,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Lmcg Investments LLC grew its stake in Pfizer by 6.8% in the 3rd quarter. Lmcg Investments LLC now owns 66,860 shares of the biopharmaceutical company’s stock valued at $1,704,000 after buying an additional 4,263 shares during the last quarter. Maryland State Retirement & Pension System grew its position in shares of Pfizer by 2.6% in the third quarter. Maryland State Retirement & Pension System now owns 283,392 shares of the biopharmaceutical company’s stock valued at $7,221,000 after purchasing an additional 7,267 shares during the last quarter. Occidental Asset Management LLC bought a new position in shares of Pfizer in the third quarter worth about $286,000. Gold Investment Management Ltd. lifted its position in shares of Pfizer by 2.1% during the 3rd quarter. Gold Investment Management Ltd. now owns 53,998 shares of the biopharmaceutical company’s stock worth $1,376,000 after purchasing an additional 1,117 shares during the last quarter. Finally, Howland Capital Management LLC boosted its stake in Pfizer by 24.2% during the 3rd quarter. Howland Capital Management LLC now owns 53,303 shares of the biopharmaceutical company’s stock valued at $1,358,000 after purchasing an additional 10,390 shares during the period. Institutional investors own 68.36% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on PFE shares. Wall Street Zen downgraded shares of Pfizer from a “buy” rating to a “hold” rating in a report on Sunday, September 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Pfizer in a research note on Wednesday, October 8th. Sanford C. Bernstein reissued a “market perform” rating and set a $30.00 target price on shares of Pfizer in a research report on Friday, October 31st. Morgan Stanley cut their price target on Pfizer from $32.00 to $28.00 and set an “equal weight” rating for the company in a report on Friday, December 12th. Finally, Guggenheim reissued a “buy” rating on shares of Pfizer in a report on Wednesday, December 17th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $27.88.

Pfizer Stock Performance

Shares of NYSE:PFE opened at $25.68 on Friday. The firm’s 50 day simple moving average is $25.35 and its 200 day simple moving average is $24.99. Pfizer Inc. has a fifty-two week low of $20.92 and a fifty-two week high of $27.69. The company has a market capitalization of $146.01 billion, a price-to-earnings ratio of 14.93 and a beta of 0.47. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.28 and a quick ratio of 0.97.

Pfizer (NYSE:PFE) last posted its earnings results on Tuesday, November 4th. The biopharmaceutical company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.08. Pfizer had a return on equity of 20.17% and a net margin of 15.65%.The firm had revenue of $16.65 billion for the quarter, compared to analyst estimates of $16.94 billion. Pfizer has set its FY 2025 guidance at 3.000-3.150 EPS. As a group, sell-side analysts forecast that Pfizer Inc. will post 2.95 earnings per share for the current year.

Pfizer Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, January 23rd will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 6.7%. The ex-dividend date is Friday, January 23rd. Pfizer’s dividend payout ratio is currently 100.00%.

About Pfizer

Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.

Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.